Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 3/2009

01.09.2009 | Original Article

Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors

verfasst von: T. B. Wang, W. S. Qiu, B. Wei, M. H. Deng, H. B. Wei, W. G. Dong

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Aim

To investigate if serum vascular endothelial growth factor (SVEGF), tissue VEGF and microvessel density (MVD) have any relation to progress and prognosis in gastrointestinal stromal tumors (GIST).

Methods

SVEGF was examined using ELISA. VEGF and MVD were examined using immunohistochemical staining.

Results

The median level of SVEGF was higher in GIST than in controls. A higher level of SVEGF and a positive expression rate of VEGF were obtained in diameter ≥5 cm, mitotic count ≥2/10 high power fields (HPF), recurrence and high risk groups. The MVD of experimental was higher than that of controls. A higher MVD was observed in mitotic count ≥2/10HPF and recurrence groups. The median level of SVEGF was higher in the VEGF positive group than in the controls. The SVEGF presented a relationship with MVD. Factors predicating poor prognosis were SVEGF and VEGF.

Conclusions

SVEGF and VEGF show a correlation with poor prognosis of GIST.
Literatur
2.
Zurück zum Zitat Chen WZ, Huang CJ, Wu MT et al (2005) Hypoxia-inducible factor-1a is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn J Clin Oncol 35(4):207–213. doi:10.1093/jjco/hyi067 PubMedCrossRef Chen WZ, Huang CJ, Wu MT et al (2005) Hypoxia-inducible factor-1a is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn J Clin Oncol 35(4):207–213. doi:10.​1093/​jjco/​hyi067 PubMedCrossRef
5.
Zurück zum Zitat Song ZJ, Gong P, Wu YE (2002) Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 8:591–595PubMed Song ZJ, Gong P, Wu YE (2002) Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 8:591–595PubMed
6.
Zurück zum Zitat Zhang H, Wu J, Meng L et al (2002) Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol 8(6):994–998PubMed Zhang H, Wu J, Meng L et al (2002) Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol 8(6):994–998PubMed
8.
9.
Zurück zum Zitat Guo J, Higashi K, Ueda Y et al (2006) Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas. J Nucl Med 47(3):419–425PubMed Guo J, Higashi K, Ueda Y et al (2006) Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas. J Nucl Med 47(3):419–425PubMed
10.
Zurück zum Zitat Ilhan N, Ilhan N, Ilhan Y et al (2004) C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 10(8):1115–1120PubMed Ilhan N, Ilhan N, Ilhan Y et al (2004) C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol 10(8):1115–1120PubMed
11.
Zurück zum Zitat Famulski W, Sulkowska M, Wincewicz A et al (2006) P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients. Neoplasma 53(1):43–48PubMed Famulski W, Sulkowska M, Wincewicz A et al (2006) P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients. Neoplasma 53(1):43–48PubMed
12.
Zurück zum Zitat Cressey R, Wattananupong O, Lertprasertsuke N et al (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis. BMC Cancer 5:128. doi:10.1186/1471-2407-5-128 PubMedCrossRef Cressey R, Wattananupong O, Lertprasertsuke N et al (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis. BMC Cancer 5:128. doi:10.​1186/​1471-2407-5-128 PubMedCrossRef
13.
Zurück zum Zitat Roumen RM, Slooter GD, Croiset van Uchelen FA et al (2005) Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients. Dis Colon Rectum 48(5):1070–1075. doi:10.1007/s10350-004-0870-y PubMedCrossRef Roumen RM, Slooter GD, Croiset van Uchelen FA et al (2005) Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients. Dis Colon Rectum 48(5):1070–1075. doi:10.​1007/​s10350-004-0870-y PubMedCrossRef
15.
Zurück zum Zitat Poncelet C, Fauvet R, Feldmann G et al (2004) Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas. J Surg Oncol 86(2):84–90. doi:10.1002/jso.20055 PubMedCrossRef Poncelet C, Fauvet R, Feldmann G et al (2004) Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas. J Surg Oncol 86(2):84–90. doi:10.​1002/​jso.​20055 PubMedCrossRef
16.
Zurück zum Zitat Potti A, Ganti AK, Tendulkar K et al (2004) Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma. J Cancer Res Clin Oncol 130(1):52–56. doi:10.1007/s00432-003-0504-0 PubMedCrossRef Potti A, Ganti AK, Tendulkar K et al (2004) Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma. J Cancer Res Clin Oncol 130(1):52–56. doi:10.​1007/​s00432-003-0504-0 PubMedCrossRef
17.
Zurück zum Zitat Hong T, Shimada Y, Uchida S et al (2001) Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int J Mol Med 8(2):141–148PubMed Hong T, Shimada Y, Uchida S et al (2001) Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int J Mol Med 8(2):141–148PubMed
18.
Zurück zum Zitat Nakayama T, Cho YC, Mine Y et al (2006) Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas. World J Gastroenterol 12(38):6182–6187PubMed Nakayama T, Cho YC, Mine Y et al (2006) Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas. World J Gastroenterol 12(38):6182–6187PubMed
19.
Zurück zum Zitat Jin T, Nakatani H, Taguchi T et al (2006) STI571 (Gleevec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1. World J Gastroenterol 12:703–708PubMed Jin T, Nakatani H, Taguchi T et al (2006) STI571 (Gleevec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1. World J Gastroenterol 12:703–708PubMed
20.
Zurück zum Zitat Takahashi R, Tanaka S, Kitadai Y et al (2003) Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 64:266–274. doi:10.1159/000069316 PubMedCrossRef Takahashi R, Tanaka S, Kitadai Y et al (2003) Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 64:266–274. doi:10.​1159/​000069316 PubMedCrossRef
22.
Zurück zum Zitat Takahashi R, Tanaka S, Hiyama T et al (2003) Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 10(4):797–802PubMed Takahashi R, Tanaka S, Hiyama T et al (2003) Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 10(4):797–802PubMed
23.
24.
Zurück zum Zitat McAuliffe JC, Lazar AJ, Yang D et al (2007) Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res 13(22 Pt 1):6727–6734. doi:10.1158/1078-0432.CCR-07-0895 PubMedCrossRef McAuliffe JC, Lazar AJ, Yang D et al (2007) Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res 13(22 Pt 1):6727–6734. doi:10.​1158/​1078-0432.​CCR-07-0895 PubMedCrossRef
25.
Zurück zum Zitat Mangia A, Chiriatti A, Ranieri G et al (2006) H pylori status and angiogenesis factors in human gastric carcinoma. World J Gastroenterol 12(34):5465–5472PubMed Mangia A, Chiriatti A, Ranieri G et al (2006) H pylori status and angiogenesis factors in human gastric carcinoma. World J Gastroenterol 12(34):5465–5472PubMed
26.
Zurück zum Zitat Cressey R, Wattananupong O, Lertprasertsuke N et al (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis. BMC Cancer 5:128. doi:10.1186/1471-2407-5-128 PubMedCrossRef Cressey R, Wattananupong O, Lertprasertsuke N et al (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis. BMC Cancer 5:128. doi:10.​1186/​1471-2407-5-128 PubMedCrossRef
27.
Zurück zum Zitat Celen O, Kahraman I, Yildirim E et al (2004) Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. Neoplasma 51(4):293–299PubMed Celen O, Kahraman I, Yildirim E et al (2004) Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. Neoplasma 51(4):293–299PubMed
28.
29.
Zurück zum Zitat Akbulut H, Altuntas F, Akbulut KG et al (2002) Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma. Cytokine 20(4):184–190. doi:10.1006/cyto.2002.1993 PubMedCrossRef Akbulut H, Altuntas F, Akbulut KG et al (2002) Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma. Cytokine 20(4):184–190. doi:10.​1006/​cyto.​2002.​1993 PubMedCrossRef
30.
Zurück zum Zitat Kumar H, Heer K, Duthie GS et al (2002) Kinetics of postoperative serum vascular endothelial growth factor (VEGF)–can it be used to predict curative resections in colorectal cancer? Anticancer Res 22(6B):3717–3722PubMed Kumar H, Heer K, Duthie GS et al (2002) Kinetics of postoperative serum vascular endothelial growth factor (VEGF)–can it be used to predict curative resections in colorectal cancer? Anticancer Res 22(6B):3717–3722PubMed
31.
Zurück zum Zitat Yoon SS, Segal NH, Olshen AB et al (2004) Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Ann Oncol 15(8):1261–1266. doi:10.1093/annonc/mdh309 PubMedCrossRef Yoon SS, Segal NH, Olshen AB et al (2004) Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Ann Oncol 15(8):1261–1266. doi:10.​1093/​annonc/​mdh309 PubMedCrossRef
33.
Zurück zum Zitat Norden-Zfoni A, Desai J, Manola J et al (2007) Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin Cancer Res 13(9):2643–2650. doi:10.1158/1078-0432.CCR-06-0919 PubMedCrossRef Norden-Zfoni A, Desai J, Manola J et al (2007) Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin Cancer Res 13(9):2643–2650. doi:10.​1158/​1078-0432.​CCR-06-0919 PubMedCrossRef
Metadaten
Titel
Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors
verfasst von
T. B. Wang
W. S. Qiu
B. Wei
M. H. Deng
H. B. Wei
W. G. Dong
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 3/2009
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-009-0315-7

Weitere Artikel der Ausgabe 3/2009

Irish Journal of Medical Science (1971 -) 3/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.